Skip to Content Facebook Feature Image

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

Business

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
Business

Business

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

2024-12-02 22:00 Last Updated At:22:15

Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency

SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, unveiled follow-up findings from the groundbreaking ScreenTrustCAD trial at the Radiological Society of North America (RSNA) 2024 Annual Meeting. This study, conducted at Capio S:t Göran Hospital in Sweden, reinforces the real-world impact of Lunit INSIGHT MMG, which has successfully replaced one of the two human readers in the hospital's double-reading breast cancer screening protocol.

The original ScreenTrustCAD trial (2021–2022), published in The Lancet Digital Health, was the first prospective interventional study to demonstrate that AI could match or even surpass traditional two-radiologist systems. Building on these findings, the hospital fully integrated AI in mid-2023 and became the first in the world to implement AI as an independent reader, fully replacing one radiologist. The new analysis compares screening performance before and after AI adoption, offering real-world validation of Lunit INSIGHT MMG's clinical and operational benefits.

Real-World Results: Efficiency Gains and Enhanced Screening Metrics

The follow-up study analyzed screening metrics from two nine-month periods: July 2018–March 2019 (pre-AI / pre-COVID) and July 2023–March 2024 (post-AI implementation).

Key findings include:

These findings demonstrate AI's ability to enhance diagnostic accuracy and significantly improve screening efficiency.

Pioneering AI Integration in Breast Screening

The adoption of Lunit INSIGHT MMG at Capio S:t Göran Hospital marks a global milestone in AI-driven healthcare. By replacing one human reader, the AI system addresses the growing radiologist shortage while maintaining the rigor of double-reading protocols. Additionally, it reduces recall rates, sparing more women the stress and anxiety of a potential cancer diagnosis. These results align with Lunit's mission to advance equitable, efficient, and high-quality cancer detection while improving patient experiences and outcomes.

"AI has become an indispensable part of our screening program, and these results showcase its potential for broader adoption," said Dr. Karin Dembrower, senior breast radiologist at Capio S:t Göran Hospital and study presenter. "By replacing one radiologist, we've reduced workloads, improved cancer detection rates, and decreased unnecessary recalls. This shift has eliminated overtime on evenings and weekends, allowing radiologists to focus on complex cases—the work we are trained for. For patients, it means faster and more accurate care. Previously, the waiting time for a clinical mammogram was five to six weeks. Now, with AI, it's down to zero."

"This follow-up to the ScreenTrustCAD trial demonstrates the transformative potential of Lunit INSIGHT MMG in real-world clinical practice," said Brandon Suh, CEO of Lunit. "By reducing reading time by 36% while improving cancer detection rates and screening efficiency, we are proving that AI is not just a tool but a critical partner in addressing global challenges like radiologist shortages and the growing demand for efficient cancer care. As AI continues to reshape radiology, we remain committed to driving innovations that empower clinicians, optimize patient outcomes, and redefine the future of breast cancer screening."

Explore Lunit's innovations at booth #4929 in the AI Showcase during RSNA 2024, December 1–6 in Chicago, Illinois.

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer. We harness AI-powered medical image analytics and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. The FDA-cleared Lunit INSIGHT suite for cancer screening serves over 4,500 hospitals and medical institutions across 55+ countries.

Lunit clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast health and screening technologies. Headquartered in Seoul, South Korea, with a network of offices worldwide, Lunit leads the global fight against cancer. Discover more at lunit.io.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

Next Article

Aleph Sponsored Juan Martín Del Potro in Farewell Match Against Novak Djokovic

2024-12-02 21:09 Last Updated At:21:25

MIAMI, Dec. 2, 2024 /PRNewswire/ -- The historic tennis player from Tandil showcased the logo of the digital marketing company, led by Argentinians Gaston Taratuta and Ignacio Vidaguren, which connects more than 26,000 advertisers with 3 billion consumers in 130 countries worldwide.

"Both Del Potro and Djokovic perfectly embody the values that have guided our company since its inception: effort, excellence, resilience, and passion. Both are elite world tennis players who have excelled on all surfaces, facing challenging contexts and circumstances throughout their careers. At Aleph, we value and share these qualities. Supporting Juan Martín in his farewell from professional tennis was a true pride and honor, and a special way to thank him for his achievements in tennis for Argentina," explained Ignacio Vidaguren, COO of the company, also born in Tandil.

17 Years on the Circuit: A History of Success and Perseverance

"We identified with the path that Juan Martín Del Potro forged throughout his career: 17 years on the circuit, thousands of flight hours, jet lag, long months away from home, difficult moments on the court, always overcoming obstacles and striving for excellence. Juan Martín won 22 tournaments on the ATP Tour, including the US Open in 2009. Additionally, he reached 13 finals and recovered from several major injuries in his career, reaching world number 3. This same mentality drives us at Aleph: never giving up, continuing to grow, and facing challenges every day, no matter the adversities," added Gaston Taratuta.

"It was a pleasure for me to partner with Aleph and have their support. In a way quite similar to my professional tennis career, Gaston and Ignacio are entrepreneurs who, from Argentina, have traveled the world building a leading digital marketing company," added Juan Martín Del Potro.

A Bridge Between Sports, Technology, and Shared Values

For Aleph, being present at this event meant much more than visibility: it was a reminder of how fundamental values transcend industries. Just as Del Potro and Djokovic have inspired millions with their excellence and resilience, Aleph leads the digital transformation in more than 130 markets, demonstrating that true connection lies in the commitment to making a difference in any field.

A Unique Moment for Argentinian and Global Sports

Juan Martín del Potro, born in Tandil on September 23, 1988, retired with an exceptional legacy. Ranked number 3 in the world at his peak, he won 22 titles throughout his career, including the US Open in 2009, and was a Davis Cup champion in 2016. His impact on sports transcends borders, with Olympic medals in London 2012 and Rio 2016, and his unmistakable fighting spirit that made him a global icon.

The event marked the return of the Tandil native after his last official match in February 2022, facing none other than Novak Djokovic, the greatest Grand Slam winner with 24 titles and a career full of historic achievements. "Two old friends, two long-time rivals, met once again to play the final challenge of 2024," promising a spectacle that combined rivalry, camaraderie, and the closing of an era in world tennis.

Accompanying images for this press release can be found here

Press contacts
press@alephholding.com
Adam Bezeczky, Global Communications Manager

About Aleph
Aleph is a global network of digital experts and technology driven solutions that enables the growth of the digital ecosystem. Operating in 130+ countries, Aleph enables media sales and payment services to over 26,000 advertisers and over 3 billion consumers. In addition, Digital Ad Expert, Aleph's premier education platform delivers top-tier, custom-tailored learning programs for individuals, businesses and governments.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Aleph Sponsored Juan Martín Del Potro in Farewell Match Against Novak Djokovic

Aleph Sponsored Juan Martín Del Potro in Farewell Match Against Novak Djokovic

Aleph Sponsored Juan Martín Del Potro in Farewell Match Against Novak Djokovic

Aleph Sponsored Juan Martín Del Potro in Farewell Match Against Novak Djokovic

Recommended Articles